206 related articles for article (PubMed ID: 28103969)
21. [Prognostic significance of intrapulmonary metastases in cases of surgically treated lung cancer].
Szöke T; Troján I; Furák J; Tiszlavicz L; Balogh A
Magy Onkol; 2003; 47(4):397-401. PubMed ID: 14716437
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
[TBL] [Abstract][Full Text] [Related]
23. A case of synchronous double primary lung cancer presenting with pleomorphic carcinoma and adenocarcinoma.
Taira N; Kawabata T; Ichi T; Kushi K; Yohena T; Kawasaki H; Ishikawa K; Kato S
Am J Case Rep; 2014 Dec; 15():576-9. PubMed ID: 25553415
[TBL] [Abstract][Full Text] [Related]
24. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
[TBL] [Abstract][Full Text] [Related]
25. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
26. [Clinical Characteristics and Prognosis of Sub-centimeter Lung Adenocarcinoma].
Mi J; Wang S; Li X; Jiang G
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):500-506. PubMed ID: 31451140
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
28. Primary synchronous small and non-small cell lung cancer in the same lung lobe: A case report.
Dzian A; Ivan F; Zdenko H; Peter S
Monaldi Arch Chest Dis; 2017 Dec; 87(3):797. PubMed ID: 29424199
[TBL] [Abstract][Full Text] [Related]
29. Synchronous Bilateral Lung Cancer With Discordant Histology.
Copur MS; Lackner R; Wedel W; Lintel N; Lintel MS; Gnatra K
Oncology (Williston Park); 2020 Feb; 34(2):55-60. PubMed ID: 32645196
[TBL] [Abstract][Full Text] [Related]
30. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
Zhang J; Wu J; Tan Q; Zhu L; Gao W
J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
[TBL] [Abstract][Full Text] [Related]
31. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
32. SUVmax and Tumor Size Predict Surgical Outcome of Synchronous Multiple Primary Lung Cancers.
Hsu HH; Ko KH; Chou YC; Lin LF; Tsai WC; Lee SC; Chang H; Huang TW
Medicine (Baltimore); 2016 Feb; 95(6):e2351. PubMed ID: 26871768
[TBL] [Abstract][Full Text] [Related]
33. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
35. Radiological classification, gene-mutation status, and surgical prognosis of synchronous multiple primary lung cancer.
Huo JW; Luo TY; He XQ; Gong JW; Lv FJ; Li Q
Eur Radiol; 2022 Jun; 32(6):4264-4274. PubMed ID: 34989846
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis and surgical treatment of double primary lung cancer].
Wang Y; Wang L; Zhang D
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):428-30. PubMed ID: 11810780
[TBL] [Abstract][Full Text] [Related]
37. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
38. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
39. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
[TBL] [Abstract][Full Text] [Related]
40. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
